MktsMarkets

NRC Health
NASDAQ: NRCKey statistics
NRC News
Stories mentioning NRC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 34,803 | 35,193 | 34,608 | 34,038 | 33,551 | 36,907 | 35,819 | 35,021 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 13,419 | 14,444 | 12,271 | 17,734 | 10,356 | 11,452 | 10,988 | 11,221 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 5,569 | 4,668 | 7,738 | 1,588 | 8,596 | 9,589 | 7,980 | 8,865 |
| Interest Income | 35.00 | 30.00 | 41.00 | 21.00 | 19.00 | 22.00 | 34.00 | 25.00 |
| Interest Expense | 1,461 | 1,032 | 899.00 | 729.00 | 706.00 | 555.00 | ||
| Other Expense | 30.00 | (61.00) | (45.00) | 4.00 | 7.00 | (6.00) | (12.00) | (11.00) |
| Pretax Income | 4,379 | 3,268 | 6,273 | 581.00 | 7,723 | 8,876 | 7,296 | 8,324 |
| Tax Provision | 1,157 | 1,471 | 2,151 | 687.00 | 1,936 | 2,315 | 1,608 | 2,149 |
| Net Income (Loss) | ||||||||
| Earnings Per Share (Basic) | 0.14 | 0.00 | 0.18 | (0.01) | 0.25 | 0.00 | 0.24 | 0.26 |
| Earnings Per Share (Diluted) | 0.14 | 0.00 | 0.18 | (0.01) | 0.25 | 0.00 | 0.24 | 0.26 |
| Weighted Average Shares Outstanding (Basic) | 21,799 | 22,383 | 22,130 | 22,658 | 22,972 | 23,703 | 23,721 | 23,871 |
| Weighted Average Shares Outstanding (Diluted) | 21,911 | 22,396 | 22,130 | 22,658 | 22,974 | 23,743 | 23,745 | 23,915 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NRC
NRC Health (NASDAQ: NRC) is a stock listed on the Nasdaq Stock Market under the ticker symbol NRC. It last traded at $25.86 (Nov 6, 2026, 4:00 PM ET), up 1.5% on the day. That gives NRC Health a market capitalisation of $570.2M and a price-to-earnings ratio of 97.3.
Over the past 52 weeks NRC has traded between $11.73 and $27.41.
Revenue for the quarter ended Mar 31, 2026 was $34.8M. Revenue was up 3.7% from $33.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | $34.8M | — |
| Dec 31, 2025 | $35.2M | — |
| Sep 30, 2025 | $34.6M | — |
| Jun 30, 2025 | $34.0M | — |
From NRC Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…